HANGZHOU TIGERMED CO. H 1 (5HZ1) — Cash Flow Reinvestment Rate
HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow Reinvestment Rate of 1.01x as of December 2025, reinvesting €1.13 Billion (capex €214.37 Million plus investments €914.13 Million) from operating cash flow of €1.12 Billion. See HANGZHOU TIGERMED CO. H 1 (5HZ1) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HANGZHOU TIGERMED CO. H 1 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. For the full cash flow conversion analysis, see 5HZ1 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for HANGZHOU TIGERMED CO. H 1 (2021–2025)
Year-by-year capital reinvestment analysis for HANGZHOU TIGERMED CO. H 1. See 5HZ1 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | €1.13 Billion | €1.12 Billion | €214.37 Million | ▼ -74.7% |
| 2024 | 3.99x | €4.38 Billion | €1.10 Billion | €356.55 Million | ▲ +271.0% |
| 2023 | 1.08x | €1.24 Billion | €1.15 Billion | €313.76 Million | ▼ -34.2% |
| 2022 | 1.64x | €2.22 Billion | €1.36 Billion | €448.60 Million | ▼ -6.6% |
| 2021 | 1.75x | €2.49 Billion | €1.42 Billion | €368.62 Million | — |